34 |
{/section} |
{/section} |
35 |
</ul> |
</ul> |
36 |
{else} |
{else} |
|
<b>Products Disclaimer</b> |
|
37 |
|
|
38 |
<p> |
<p><b>Products Disclaimer</b></p> |
39 |
Product mentions on this web site are intended for information |
<p>Product mentions on this web site are intended for information purposes only. |
40 |
purposes only. Some of the products listed herein are available upon |
Some of the products listed herein are available upon prescription from a medical |
41 |
prescription from a medical doctor only and not all products may |
doctor only and not all products may be available in all countries. Product |
42 |
be available in all countries. Product mentions are not intended |
mentions are not intended to provide complete medical information and patients |
43 |
to provide complete medical information and patients should always |
should always obtain complete medical information from the product's information |
44 |
obtain complete medical information from the product's information |
leaflet and/or by discussing the appropriate use of the medicine(s) directly |
45 |
leaflet and/or by discussing the appropriate use of the medicine(s) |
with their prescribing physician. Product mentions on this web site are based |
46 |
directly with their prescribing physician. Information on these |
on Summary of Product Characteristics officially approved by Croatian Ministry |
47 |
products may vary by country. Patients and physicians should check with |
of Health and extent of information on these products may vary by country. Patients |
48 |
local medical resources and regulatory authorities for information |
and physicians should check with local medical resources and regulatory authorities |
49 |
appropriate to their country. According to regulations in in a great |
for information appropriate to their country. According to regulations in a |
50 |
number of countries, PLIVA's ability to provide information and/or |
great number of countries, PLIVA's ability to provide information and/or to |
51 |
to respond directly to patient's questions regarding its prescription |
respond directly to patient's questions regarding its prescription products |
52 |
products may be limited. |
may be limited. </p> |
|
</p> |
|
53 |
|
|
54 |
{/if} |
{/if} |